TY  - GEN
AU  - Goyard,David
AU  - Kónya,Bálint
AU  - Chajistamatiou,Aikaterini S
AU  - Chrysina,Evangelia D
AU  - Leroy,Jérémy
AU  - Balzarin,Sophie
AU  - Tournier,Michel
AU  - Tousch,Didier
AU  - Petit,Pierre
AU  - Duret,Cédric
AU  - Maurel,Patrick
AU  - Somsák,László
AU  - Docsa,Tibor
AU  - Gergely,Pál
AU  - Praly,Jean-Pierre
AU  - Azay-Milhau,Jacqueline
AU  - Vidal,Sébastien
TI  - Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition
SN  - 1768-3254
PY  - 2016///1011
KW  - Animals
KW  - Diabetes Mellitus, Experimental
KW  - drug therapy
KW  - Diabetes Mellitus, Type 2
KW  - Disease Models, Animal
KW  - Dose-Response Relationship, Drug
KW  - Enzyme Inhibitors
KW  - chemical synthesis
KW  - Glucose
KW  - analogs & derivatives
KW  - Glycogen Phosphorylase
KW  - antagonists & inhibitors
KW  - Hypoglycemic Agents
KW  - Isoxazoles
KW  - Molecular Structure
KW  - Rats
KW  - Rats, Zucker
KW  - Spiro Compounds
KW  - Structure-Activity Relationship
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ejmech.2015.12.004
ER  -